Global Cardiologist Physician Survey: Drug-Coated Balloons, Transcatheter Heart Valve Implantation and Fractional Flow Reserve Guidewires (2010-2020)
The Global Cardiologist Survey is a global survey regarding end-user attitudes and perceptions towards drug-coated balloons (DCBs), transcatheter heart valve implantation (THVI) and fractional flow reserve (FFR) guidewires. Responses from interventional cardiologists from the United States and 30 other countries were gathered in person at the recent Transcatheter Cardiovascular Therapeutics (TCT) conference. Regions include South America, Europe, Asia, Middle East and North America.
RESEARCH METHODOLOGY
1.1 RESEARCH OVERVIEW
1.2 RESEARCH SERVICES
1.3 SURVEY METHODOLOGY
DRUG-COATED BALLOONS
2.1 BACKGROUND
2.1.1 Peripheral Arterial Disease and Coronary Arterial Disease
2.1.2 Endovascular Treatment of Stenosis
2.2 MARKET ANALYSIS AND FORECAST
2.2.1 Global Drug-Coated Balloon Market
2.3 ANGIOPLASTY PROCEDURES
2.3.1 Average Coronary Angioplasty Procedures per Month by Region
2.3.2 Average Peripheral Angioplasty Procedures per Month by Region
2.4 ANGIOPLASTY PROCEDURES AND DRUG-COATED BALLOONS
2.4.1 Coronary Angioplasty Procedures and Drug-Coated Balloon Use by Region
2.4.2 Peripheral Angioplasty Procedures and Drug-Coated Balloon Use by Region
2.5 STENT PLACEMENT PROCEDURES
2.5.1 Average Coronary Stent Placement Procedures per Month by Region
2.5.2 Average Peripheral Stent Placement Procedures per Month by Region
2.6 STENT PLACEMENT AND DRUG-COATED BALLOONS
2.6.1 Stent Placement and Drug-Coated Balloon Use by Region
2.7 DRUG-COATED BALLOON DEVICE PREFERENCE
2.7.1 Coronary Drug-Coated Balloon Device Preference by Region
2.7.2 Peripheral Drug-Coated Balloon Device Preference by Region
2.8 DRUG-COATED BALLOON DRAWBACKS
2.8.1 Drug-Coated Balloon Drawbacks by Region
TRANSCATHETER HEART VALVE IMPLANTATION
3.1 BACKGROUND
3.1.1 Patient Population
3.2 MARKET ANALYSIS AND FORECAST
3.2.1 Global Transcatheter Heart Valve Implantation Device Market
3.3 TRANSCATHETER HEART VALVE PROCEDURES
3.3.1 Current Transcatheter Heart Valve Procedures per Year by Region
3.3.2 Future Transcatheter Heart Valve Procedures per Year by Region
3.4 REASONS FOR PERFORMING TRANSCATHETER VALVE IMPLANTATIONS
3.4.1 Transcatheter Valve Implantation Clinical Outcomes Responses by Region
3.4.2 Transcatheter Valve Implantation Lower Price Responses by Region
3.4.3 Transcatheter Valve Implantation Easier Patient Recovery Responses by Region
3.4.4 Transcatheter Valve Implantation Other Responses by Region
3.5 TRANSCATHETER AORTIC VALVE IMPLANTATION DEVICE PREFERENCE
3.5.1 SAPIEN Device Preference by Region
3.5.2 CoreValve Device Preference by Region
3.6 MOST IMPORTANT TRANSCATHETER HEART IMPLANTATION DEVICE FEATURES
3.6.1 Clinical Outcomes Responses by Region
3.6.2 Lower Price Responses by Region
3.6.3 Manufacturer/Distributor Relationships Responses by Region
3.6.4 Ease-of-Use Responses by Region
3.6.5 Other Responses by Region
3.7 TRANSCATHETER VALVE IMPLANTATION AND PACEMAKERS
3.7.1 Transcatheter Valve Implantation and Pacemaker Responses by Region
3.8 TRANSCATHETER VALVE IMPLANTATION COMPLICATIONS
3.8.1 Transcatheter Valve Implantation Complications Responses by Region
3.9 FUTURE TRANSCATHETER HEART VALVE DEVICES
3.9.1 Tricuspid Valve Responses by Region
3.9.2 Mitral Valve Responses by Region
3.9.3 Pulmonary Valve Responses by Region
3.10 FUTURE TRANSCATHETER HEART VALVE PROCEDURES
3.10.1 Tricuspid Valve Procedure Responses by Region
3.10.2 Mitral Valve Procedure Responses by Region
3.10.3 Pulmonary Valve Procedure Responses by Region
FRACTIONAL FLOW RESERVE GUIDEWIRES
4.1 BACKGROUND
4.2 CLINICAL TRIALS AND RESULTS
4.2.1 DEFER
4.2.2 FAME
4.2.3 FAME II
4.3 MARKET ANALYSIS AND FORECAST
4.3.1 Fractional Flow Reserve Guidewire Market
4.4 ANGIOGRAPHY PROCEDURES
4.4.1 Average Angiography Procedures per Month by Region
4.4.2 Percentage of Angiographies That Use FFR Guidewires by Region
4.5 FFR GUIDEWIRE AND STENT USE
4.5.1 Percentage of Fewer Stents Used per Procedure by Region
4.5.2 Average Fewer Stent Used per Procedure by Region
4.6 FFR GUIDEWIRE PRODUCT PREFERENCE
4.6.1 PressureWire Certus Device Preference by Region
4.6.2 FloWire Doppler Device Preference by Region
4.6.3 PressureWire Aeris Device Preference by Region
4.6.4 Primewire Prestige Device Preference by Region
4.6.5 Primewire Prestige PLUS Device Preference by Region
4.6.6 ComboWire XT Device Preference by Region
4.6.7 Other Device Preference by Region
4.7 MOST IMPORTANT FFR DEVICE FEATURES
4.7.1 Availability of Devices Responses by Region
4.7.2 Price Responses by Region
4.7.3 Clinical Outcomes Responses by Region
4.7.4 Existing Business Relationships Responses by Region
4.8 REASONS FOR NOT USING FFR GUIDEWIRES
4.8.1 Price Responses by Region
4.8.2 Availability of Devices Responses by Region
4.8.3 Use of OCT/CT/MRI Devices Responses by Region
4.8.4 Data Not Convincing Responses by Region
4.8.5 Existing Business Relationships Responses by Region
4.8.6 Other Responses by Region
1.1 RESEARCH OVERVIEW
1.2 RESEARCH SERVICES
1.3 SURVEY METHODOLOGY
DRUG-COATED BALLOONS
2.1 BACKGROUND
2.1.1 Peripheral Arterial Disease and Coronary Arterial Disease
2.1.2 Endovascular Treatment of Stenosis
2.2 MARKET ANALYSIS AND FORECAST
2.2.1 Global Drug-Coated Balloon Market
2.3 ANGIOPLASTY PROCEDURES
2.3.1 Average Coronary Angioplasty Procedures per Month by Region
2.3.2 Average Peripheral Angioplasty Procedures per Month by Region
2.4 ANGIOPLASTY PROCEDURES AND DRUG-COATED BALLOONS
2.4.1 Coronary Angioplasty Procedures and Drug-Coated Balloon Use by Region
2.4.2 Peripheral Angioplasty Procedures and Drug-Coated Balloon Use by Region
2.5 STENT PLACEMENT PROCEDURES
2.5.1 Average Coronary Stent Placement Procedures per Month by Region
2.5.2 Average Peripheral Stent Placement Procedures per Month by Region
2.6 STENT PLACEMENT AND DRUG-COATED BALLOONS
2.6.1 Stent Placement and Drug-Coated Balloon Use by Region
2.7 DRUG-COATED BALLOON DEVICE PREFERENCE
2.7.1 Coronary Drug-Coated Balloon Device Preference by Region
2.7.2 Peripheral Drug-Coated Balloon Device Preference by Region
2.8 DRUG-COATED BALLOON DRAWBACKS
2.8.1 Drug-Coated Balloon Drawbacks by Region
TRANSCATHETER HEART VALVE IMPLANTATION
3.1 BACKGROUND
3.1.1 Patient Population
3.2 MARKET ANALYSIS AND FORECAST
3.2.1 Global Transcatheter Heart Valve Implantation Device Market
3.3 TRANSCATHETER HEART VALVE PROCEDURES
3.3.1 Current Transcatheter Heart Valve Procedures per Year by Region
3.3.2 Future Transcatheter Heart Valve Procedures per Year by Region
3.4 REASONS FOR PERFORMING TRANSCATHETER VALVE IMPLANTATIONS
3.4.1 Transcatheter Valve Implantation Clinical Outcomes Responses by Region
3.4.2 Transcatheter Valve Implantation Lower Price Responses by Region
3.4.3 Transcatheter Valve Implantation Easier Patient Recovery Responses by Region
3.4.4 Transcatheter Valve Implantation Other Responses by Region
3.5 TRANSCATHETER AORTIC VALVE IMPLANTATION DEVICE PREFERENCE
3.5.1 SAPIEN Device Preference by Region
3.5.2 CoreValve Device Preference by Region
3.6 MOST IMPORTANT TRANSCATHETER HEART IMPLANTATION DEVICE FEATURES
3.6.1 Clinical Outcomes Responses by Region
3.6.2 Lower Price Responses by Region
3.6.3 Manufacturer/Distributor Relationships Responses by Region
3.6.4 Ease-of-Use Responses by Region
3.6.5 Other Responses by Region
3.7 TRANSCATHETER VALVE IMPLANTATION AND PACEMAKERS
3.7.1 Transcatheter Valve Implantation and Pacemaker Responses by Region
3.8 TRANSCATHETER VALVE IMPLANTATION COMPLICATIONS
3.8.1 Transcatheter Valve Implantation Complications Responses by Region
3.9 FUTURE TRANSCATHETER HEART VALVE DEVICES
3.9.1 Tricuspid Valve Responses by Region
3.9.2 Mitral Valve Responses by Region
3.9.3 Pulmonary Valve Responses by Region
3.10 FUTURE TRANSCATHETER HEART VALVE PROCEDURES
3.10.1 Tricuspid Valve Procedure Responses by Region
3.10.2 Mitral Valve Procedure Responses by Region
3.10.3 Pulmonary Valve Procedure Responses by Region
FRACTIONAL FLOW RESERVE GUIDEWIRES
4.1 BACKGROUND
4.2 CLINICAL TRIALS AND RESULTS
4.2.1 DEFER
4.2.2 FAME
4.2.3 FAME II
4.3 MARKET ANALYSIS AND FORECAST
4.3.1 Fractional Flow Reserve Guidewire Market
4.4 ANGIOGRAPHY PROCEDURES
4.4.1 Average Angiography Procedures per Month by Region
4.4.2 Percentage of Angiographies That Use FFR Guidewires by Region
4.5 FFR GUIDEWIRE AND STENT USE
4.5.1 Percentage of Fewer Stents Used per Procedure by Region
4.5.2 Average Fewer Stent Used per Procedure by Region
4.6 FFR GUIDEWIRE PRODUCT PREFERENCE
4.6.1 PressureWire Certus Device Preference by Region
4.6.2 FloWire Doppler Device Preference by Region
4.6.3 PressureWire Aeris Device Preference by Region
4.6.4 Primewire Prestige Device Preference by Region
4.6.5 Primewire Prestige PLUS Device Preference by Region
4.6.6 ComboWire XT Device Preference by Region
4.6.7 Other Device Preference by Region
4.7 MOST IMPORTANT FFR DEVICE FEATURES
4.7.1 Availability of Devices Responses by Region
4.7.2 Price Responses by Region
4.7.3 Clinical Outcomes Responses by Region
4.7.4 Existing Business Relationships Responses by Region
4.8 REASONS FOR NOT USING FFR GUIDEWIRES
4.8.1 Price Responses by Region
4.8.2 Availability of Devices Responses by Region
4.8.3 Use of OCT/CT/MRI Devices Responses by Region
4.8.4 Data Not Convincing Responses by Region
4.8.5 Existing Business Relationships Responses by Region
4.8.6 Other Responses by Region
LIST OF CHARTS
Chart 1 1: Regions and Countries Surveyed, 2013
Chart 3 1: Drug-Coated Balloon Market, Global, 2013 – 2016
Chart 3 2: Average Coronary Angioplasty Procedures per Month by Region, 2013
Chart 3 3: Average Peripheral Angioplasty Procedures per Month by Region, 2013
Chart 3 4: Percentage of Coronary Procedures and Drug-Coated Balloon Use, Global, 2013
Chart 3 5: Percentage of Peripheral Procedures and Drug-Coated Balloon Use, Global, 2013
Chart 3 6 : Average Coronary Stent Placement Procedures per Month by Region, 2013
Chart 3 7 : Average Peripheral Stent Placement Procedures per Month by Region, 2013
Chart 3 8: Percentage of Stent Placement Procedures Involving Drug-Coated Balloon Use by Region, Global, 2013
Chart 3 9: Coronary Drug-Coated Balloon Device Preference, Global, 2013
Chart 3 10: Coronary Drug-Coated Balloon Device Preference, South America, 2013
Chart 3 11: Coronary Drug-Coated Balloon Device Preference, Europe, 2013
Chart 3 12: Coronary Drug-Coated Balloon Device Preference, Asia, 2013
Chart 3 13: Coronary Drug-Coated Balloon Device Preference, Middle East, 2013
Chart 3 14: Coronary Drug-Coated Balloon Device Preference, North America, 2013
Chart 3 15: Peripheral Drug-Coated Balloon Device Preference, Global, 2013
Chart 3 16: Peripheral Drug-Coated Balloon Device Preference, South America, 2013
Chart 3 17: Peripheral Drug-Coated Balloon Device Preference, Europe, 2013
Chart 3 18: Peripheral Drug-Coated Balloon Device Preference, Asia, 2013
Chart 3 19: Peripheral Drug-Coated Balloon Device Preference, Middle East, 2013
Chart 3 20: Peripheral Drug-Coated Balloon Device Preference, North America, 2013
Chart 3 21: Drug-Coated Balloon Drawbacks, Global, 2013
Chart 3 22: Drug-Coated Balloon Drawbacks, South America, 2013
Chart 3 23: Drug-Coated Balloon Drawbacks, Europe, 2013
Chart 3 24: Drug-Coated Balloon Drawbacks, Asia, 2013
Chart 3 25: Drug-Coated Balloon Drawbacks, Middle East, 2013
Chart 3 26: Drug-Coated Balloon Drawbacks, North America, 2013
Chart 4 1: Global Transcatheter Heart Valve Implantation Device Market, 2013 – 2016
Chart 4 2: Average Current Transcatheter Heart Valve Procedures per Year by Region, 2013
Chart 4 3: Average Future Transcatheter Heart Valve Procedures per Year by Region, 2013
Chart 4 4: Reasons for Performing Transcatheter Valve Implantations, Global, 2013
Chart 4 5: Reasons for Performing Transcatheter Valve Implantations, South America, 2013
Chart 4 6: Reasons for Performing Transcatheter Valve Implantations, Europe, 2013
Chart 4 7: Reasons for Performing Transcatheter Valve Implantations, Asia, 2013
Chart 4 8: Reasons for Performing Transcatheter Valve Implantations, Middle East, 2013
Chart 4 9: Reasons for Performing Transcatheter Valve Implantations, North America, 2013
Chart 4 10: Transcatheter Aortic Valve Implantation Device Preference by Region, Global, 2013
Chart 4 11: Most Important Transcatheter Heart Implantation Device Features, Global, 2013
Chart 4 12: Most Important Transcatheter Heart Implantation Device Features, South America, 2013
Chart 4 13: Most Important Transcatheter Heart Implantation Device Features, Europe, 2013
Chart 4 14: Most Important Transcatheter Heart Implantation Device Features, Asia, 2013
Chart 4 154 16: Most Important Transcatheter Heart Implantation Device Features, Middle East, 2013
Chart 4 17: Most Important Transcatheter Heart Implantation Device Features, North America, 2013
Chart 4 18: Transcatheter Valve Implantation and Pacemaker Responses by Region, Global, 2013
Chart 4 19: Transcatheter Valve Implantation Complications Responses by Region, Global, 2013
Chart 4 20: Future Transcatheter Heart Valve Device Responses by Region, Global, 2013
Chart 4 21: Future Transcatheter Heart Valve Device Responses by Region, South America, 2013
Chart 4 22: Future Transcatheter Heart Valve Device Responses by Region, Europe, 2013
Chart 4 23: Future Transcatheter Heart Valve Device Responses by Region, Asia, 2013
Chart 4 24: Future Transcatheter Heart Valve Device Responses by Region, Middle East, 2013
Chart 4 25: Future Transcatheter Heart Valve Device Responses by Region, North America, 2013
Chart 4 26: Future Transcatheter Heart Valve Procedure Responses by Region, Global, 2013
Chart 4 27: Future Transcatheter Heart Valve Procedure Responses by Region, South America, 2013
Chart 4 28: Future Transcatheter Heart Valve Procedure Responses by Region, Europe, 2013
Chart 4 29: Future Transcatheter Heart Valve Procedure Responses by Region, Asia, 2013
Chart 4 30: Future Transcatheter Heart Valve Procedure Responses by Region, Middle East, 2013
Chart 4 31: Future Transcatheter Heart Valve Procedure Responses by Region, North America, 2013
Chart 5 1: Fractional Flow Reserve Guidewire Market, U.S., 2013 – 2016
Chart 5 2: Fractional Flow Reserve Guide Market, U.S., 2013 – 2016
Chart 5 3: Average Angiography Procedures per Month by Region, 2013
Chart 5 4: Percentage of Angiographies That Use FFR Guidewires by Region, 2013
Chart 5 5: Percentage of Fewer Stents Used per Procedure by Region, 2013
Chart 5 6: Average Fewer Stents Used per Procedure by Region, Global, 2013
Chart 5 7: FFR Guidewire Product Preference, Global, 2013
Chart 5 8: FFR Guidewire Product Preference, South America, 2013
Chart 5 9: FFR Guidewire Product Preference, Europe, 2013
Chart 5 10: FFR Guidewire Product Preference, Asia, 2013
Chart 5 11: FFR Guidewire Product Preference, Middle East, 2013
Chart 5 12: FFR Guidewire Product Preference, North America, 2013
Chart 5 13: Most Important FFR Device Features, Global, 2013
Chart 5 14: Most Important FFR Device Features, South America, 2013
Chart 5 15: Most Important FFR Device Features, Europe, 2013
Chart 5 16: Most Important FFR Device Features, Asia, 2013
Chart 5 17: Most Important FFR Device Features, Middle East, 2013
Chart 5 18: Most Important FFR Device Features, North America, 2013
Chart 5 19: Reasons for Not Using FFR Guidewires, Global, 2013
Chart 5 20: Reasons for Not Using FFR Guidewires, South America, 2013
Chart 5 21: Reasons for Not Using FFR Guidewires, Europe, 2013
Chart 5 22: Reasons for Not Using FFR Guidewires, Asia, 2013
Chart 5 23: Reasons for Not Using FFR Guidewires, Middle East, 2013
Chart 5 24: Reasons for Not Using FFR Guidewires, North America, 2013
Chart 1 1: Regions and Countries Surveyed, 2013
Chart 3 1: Drug-Coated Balloon Market, Global, 2013 – 2016
Chart 3 2: Average Coronary Angioplasty Procedures per Month by Region, 2013
Chart 3 3: Average Peripheral Angioplasty Procedures per Month by Region, 2013
Chart 3 4: Percentage of Coronary Procedures and Drug-Coated Balloon Use, Global, 2013
Chart 3 5: Percentage of Peripheral Procedures and Drug-Coated Balloon Use, Global, 2013
Chart 3 6 : Average Coronary Stent Placement Procedures per Month by Region, 2013
Chart 3 7 : Average Peripheral Stent Placement Procedures per Month by Region, 2013
Chart 3 8: Percentage of Stent Placement Procedures Involving Drug-Coated Balloon Use by Region, Global, 2013
Chart 3 9: Coronary Drug-Coated Balloon Device Preference, Global, 2013
Chart 3 10: Coronary Drug-Coated Balloon Device Preference, South America, 2013
Chart 3 11: Coronary Drug-Coated Balloon Device Preference, Europe, 2013
Chart 3 12: Coronary Drug-Coated Balloon Device Preference, Asia, 2013
Chart 3 13: Coronary Drug-Coated Balloon Device Preference, Middle East, 2013
Chart 3 14: Coronary Drug-Coated Balloon Device Preference, North America, 2013
Chart 3 15: Peripheral Drug-Coated Balloon Device Preference, Global, 2013
Chart 3 16: Peripheral Drug-Coated Balloon Device Preference, South America, 2013
Chart 3 17: Peripheral Drug-Coated Balloon Device Preference, Europe, 2013
Chart 3 18: Peripheral Drug-Coated Balloon Device Preference, Asia, 2013
Chart 3 19: Peripheral Drug-Coated Balloon Device Preference, Middle East, 2013
Chart 3 20: Peripheral Drug-Coated Balloon Device Preference, North America, 2013
Chart 3 21: Drug-Coated Balloon Drawbacks, Global, 2013
Chart 3 22: Drug-Coated Balloon Drawbacks, South America, 2013
Chart 3 23: Drug-Coated Balloon Drawbacks, Europe, 2013
Chart 3 24: Drug-Coated Balloon Drawbacks, Asia, 2013
Chart 3 25: Drug-Coated Balloon Drawbacks, Middle East, 2013
Chart 3 26: Drug-Coated Balloon Drawbacks, North America, 2013
Chart 4 1: Global Transcatheter Heart Valve Implantation Device Market, 2013 – 2016
Chart 4 2: Average Current Transcatheter Heart Valve Procedures per Year by Region, 2013
Chart 4 3: Average Future Transcatheter Heart Valve Procedures per Year by Region, 2013
Chart 4 4: Reasons for Performing Transcatheter Valve Implantations, Global, 2013
Chart 4 5: Reasons for Performing Transcatheter Valve Implantations, South America, 2013
Chart 4 6: Reasons for Performing Transcatheter Valve Implantations, Europe, 2013
Chart 4 7: Reasons for Performing Transcatheter Valve Implantations, Asia, 2013
Chart 4 8: Reasons for Performing Transcatheter Valve Implantations, Middle East, 2013
Chart 4 9: Reasons for Performing Transcatheter Valve Implantations, North America, 2013
Chart 4 10: Transcatheter Aortic Valve Implantation Device Preference by Region, Global, 2013
Chart 4 11: Most Important Transcatheter Heart Implantation Device Features, Global, 2013
Chart 4 12: Most Important Transcatheter Heart Implantation Device Features, South America, 2013
Chart 4 13: Most Important Transcatheter Heart Implantation Device Features, Europe, 2013
Chart 4 14: Most Important Transcatheter Heart Implantation Device Features, Asia, 2013
Chart 4 154 16: Most Important Transcatheter Heart Implantation Device Features, Middle East, 2013
Chart 4 17: Most Important Transcatheter Heart Implantation Device Features, North America, 2013
Chart 4 18: Transcatheter Valve Implantation and Pacemaker Responses by Region, Global, 2013
Chart 4 19: Transcatheter Valve Implantation Complications Responses by Region, Global, 2013
Chart 4 20: Future Transcatheter Heart Valve Device Responses by Region, Global, 2013
Chart 4 21: Future Transcatheter Heart Valve Device Responses by Region, South America, 2013
Chart 4 22: Future Transcatheter Heart Valve Device Responses by Region, Europe, 2013
Chart 4 23: Future Transcatheter Heart Valve Device Responses by Region, Asia, 2013
Chart 4 24: Future Transcatheter Heart Valve Device Responses by Region, Middle East, 2013
Chart 4 25: Future Transcatheter Heart Valve Device Responses by Region, North America, 2013
Chart 4 26: Future Transcatheter Heart Valve Procedure Responses by Region, Global, 2013
Chart 4 27: Future Transcatheter Heart Valve Procedure Responses by Region, South America, 2013
Chart 4 28: Future Transcatheter Heart Valve Procedure Responses by Region, Europe, 2013
Chart 4 29: Future Transcatheter Heart Valve Procedure Responses by Region, Asia, 2013
Chart 4 30: Future Transcatheter Heart Valve Procedure Responses by Region, Middle East, 2013
Chart 4 31: Future Transcatheter Heart Valve Procedure Responses by Region, North America, 2013
Chart 5 1: Fractional Flow Reserve Guidewire Market, U.S., 2013 – 2016
Chart 5 2: Fractional Flow Reserve Guide Market, U.S., 2013 – 2016
Chart 5 3: Average Angiography Procedures per Month by Region, 2013
Chart 5 4: Percentage of Angiographies That Use FFR Guidewires by Region, 2013
Chart 5 5: Percentage of Fewer Stents Used per Procedure by Region, 2013
Chart 5 6: Average Fewer Stents Used per Procedure by Region, Global, 2013
Chart 5 7: FFR Guidewire Product Preference, Global, 2013
Chart 5 8: FFR Guidewire Product Preference, South America, 2013
Chart 5 9: FFR Guidewire Product Preference, Europe, 2013
Chart 5 10: FFR Guidewire Product Preference, Asia, 2013
Chart 5 11: FFR Guidewire Product Preference, Middle East, 2013
Chart 5 12: FFR Guidewire Product Preference, North America, 2013
Chart 5 13: Most Important FFR Device Features, Global, 2013
Chart 5 14: Most Important FFR Device Features, South America, 2013
Chart 5 15: Most Important FFR Device Features, Europe, 2013
Chart 5 16: Most Important FFR Device Features, Asia, 2013
Chart 5 17: Most Important FFR Device Features, Middle East, 2013
Chart 5 18: Most Important FFR Device Features, North America, 2013
Chart 5 19: Reasons for Not Using FFR Guidewires, Global, 2013
Chart 5 20: Reasons for Not Using FFR Guidewires, South America, 2013
Chart 5 21: Reasons for Not Using FFR Guidewires, Europe, 2013
Chart 5 22: Reasons for Not Using FFR Guidewires, Asia, 2013
Chart 5 23: Reasons for Not Using FFR Guidewires, Middle East, 2013
Chart 5 24: Reasons for Not Using FFR Guidewires, North America, 2013
LIST OF FIGURES
Figure 1 1: Regions and Countries Surveyed, 2013
Figure 3 1: Drug-Coated Balloon Market, Global, 2013 – 2016
Figure 3 2: Average Coronary Angioplasty Procedures by Region, Global, 2013
Figure 3 3: Average Peripheral Angioplasty Procedures by Region, Global, 2013
Figure 3 4: Percentage of Coronary Angioplasty Procedures and Drug-Coated Balloon Use by Region, Global, 2013
Figure 3 5: Percentage of Peripheral Angioplasty Procedures and Drug-Coated Balloon Use by Region, Global, 2013
Figure 3 6: Average Coronary Stent Placement Procedures per Month by Region, Global, 2013
Figure 3 7: Average Peripheral Stent Placement Procedures per Month by Region, Global, 2013
Figure 3 8: Percentage of Stent Placement Procedures Involving Drug-Coated Balloon Use by Region, Global, 2013
Figure 3 9: Coronary Drug-Coated Balloon Device Preference by Region, Global, 2013
Figure 3 10: Peripheral Drug-Coated Balloon Device Preference by Region, Global, 2013
Figure 3 11: Drug-Coated Balloon Drawbacks by Region, Global, 2013
Figure 4 1: Global Transcatheter Heart Valve Implantation Device Market, 2013 – 2016
Figure 4 2: Average Current Transcatheter Heart Valve Procedures per Year by Region, Global, 2013
Figure 4 3: Average Future Transcatheter Heart Valve Procedures per Year by Region, Global, 2013
Figure 4 4: Transcatheter Valve Implantation Clinical Outcome Responses by Region, Global, 2013
Figure 4 5: Transcatheter Valve Implantation Lower Price Responses by Region, Global, 2013
Figure 4 6: Transcatheter Valve Implantation Easier Patient Recovery Responses by Region, Global, 2013
Figure 4 7: Transcatheter Valve Implantation Other Responses by Region, Global, 2013
Figure 4 8: Transcatheter Aortic Valve Implantation SAPIEN Preference by Region, Global, 2013
Figure 4 9: Transcatheter Aortic Valve Implantation CoreValve Preference by Region, Global, 2013
Figure 4 10: Clinical Outcome Responses by Region, Most Important Transcatheter Heart Implantation Device Features, Global, 2013
Figure 4 11: Lower Price Responses by Region, Most Important Transcatheter Heart Implantation Device Features, Global, 2013
Figure 4 12: Manufacturer/Distributor Relationships Responses by Region, Most Important Transcatheter Heart Implantation Device Features, Global, 2013
Figure 4 13: Ease-of-Use Reponses by Region, Most Important Transcatheter Heart Implantation Device Features, Global, 2013
Figure 4 14: Other Responses by Region, Most Important Transcatheter Heart Implantation Device Features, Global, 2013
Figure 4 15: Transcatheter Valve Implantation and Pacemaker Responses by Region, Global, 2013
Figure 4 16: Transcatheter Valve Implantation Complications Responses by Region, Global, 2013
Figure 4 17: Future Transcatheter Heart Valve Tricuspid Responses by Region, Global, 2013
Figure 4 18: Future Transcatheter Heart Valve Mitral Responses by Region, Global, 2013
Figure 4 19: Future Transcatheter Heart Valve Pulmonary Responses by Region, Global, 2013
Figure 4 20: Future Transcatheter Tricuspid Valve Procedure Responses by Region, Global, 2013
Figure 4 21: Future Transcatheter Mitral Valve Procedure Responses by Region, Global, 2013
Figure 4 22: Future Transcatheter Pulmonary Valve Procedure Responses by Region, Global, 2013
Figure 5 1: Fractional Flow Reserve Guidewire Market, U.S., 2013 – 2016
Figure 5 2: Fractional Flow Reserve Guide Market, U.S., 2013 – 2016
Figure 5 3: Average Angiography Procedures per Month by Region, Global, 2013
Figure 5 4: Percentage of Angiographies That Use FFR Guidewires by Region, Global, 2013
Figure 5 5: Percentage of Fewer Stents Used per Procedure by Region, Global, 2013
Figure 5 6: Average Fewer Stents Used per Procedure by Region, Global, 2013
Figure 5 7: PressureWire Certus Device Preference by Region, Global, 2013
Figure 5 8: FloWire Doppler Device Preference by Region, Global, 2013
Figure 5 9: PressureWire Aeris Device Preference by Region, Global, 2013
Figure 5 10: Primewire Prestige Device Preference by Region, Global, 2013
Figure 5 11: Primewire Prestige PLUS Device Preference by Region, Global, 2013
Figure 5 12: ComboWire XT Device Preference by Region, Global, 2013
Figure 5 13: Other Device Preference by Region, Global, 2013
Figure 5 14: Availability of Devices Responses by Region, Most Important FFR Device Features, Global, 2013
Figure 5 15: Price Responses by Region, Most Important FFR Device Features, Global, 2013
Figure 5 16: Clinical Outcomes Responses by Region, Most Important FFR Device Features, Global, 2013
Figure 5 17: Existing Business Relationships Responses by Region, Most Important FFR Device Features, Global, 2013
Figure 5 18: Unknown Responses by Region, Most Important FFR Device Features, Global, 2013
Figure 5 19: Price Responses by Region, Reasons for Not Using FFR Guidewires, Global, 2013
Figure 5 20: Availability of Devices Responses by Region, Reasons for Not Using FFR Guidewires, Global, 2013
Figure 5 21: Use of OCT/CT/MRI Devices Responses by Region, Reasons for Not Using FFR Guidewires, Global, 2013
Figure 5 22: Data Not Convincing Responses by Region, Reasons for Not Using FFR Guidewires, Global, 2013
Figure 5 23: Existing Business Relationships Responses by Region, Reasons for Not Using FFR Guidewires, Global, 2013
Figure 5 24: Other Responses by Region, Reasons for Not Using FFR Guidewires, Global, 2013
Figure 1 1: Regions and Countries Surveyed, 2013
Figure 3 1: Drug-Coated Balloon Market, Global, 2013 – 2016
Figure 3 2: Average Coronary Angioplasty Procedures by Region, Global, 2013
Figure 3 3: Average Peripheral Angioplasty Procedures by Region, Global, 2013
Figure 3 4: Percentage of Coronary Angioplasty Procedures and Drug-Coated Balloon Use by Region, Global, 2013
Figure 3 5: Percentage of Peripheral Angioplasty Procedures and Drug-Coated Balloon Use by Region, Global, 2013
Figure 3 6: Average Coronary Stent Placement Procedures per Month by Region, Global, 2013
Figure 3 7: Average Peripheral Stent Placement Procedures per Month by Region, Global, 2013
Figure 3 8: Percentage of Stent Placement Procedures Involving Drug-Coated Balloon Use by Region, Global, 2013
Figure 3 9: Coronary Drug-Coated Balloon Device Preference by Region, Global, 2013
Figure 3 10: Peripheral Drug-Coated Balloon Device Preference by Region, Global, 2013
Figure 3 11: Drug-Coated Balloon Drawbacks by Region, Global, 2013
Figure 4 1: Global Transcatheter Heart Valve Implantation Device Market, 2013 – 2016
Figure 4 2: Average Current Transcatheter Heart Valve Procedures per Year by Region, Global, 2013
Figure 4 3: Average Future Transcatheter Heart Valve Procedures per Year by Region, Global, 2013
Figure 4 4: Transcatheter Valve Implantation Clinical Outcome Responses by Region, Global, 2013
Figure 4 5: Transcatheter Valve Implantation Lower Price Responses by Region, Global, 2013
Figure 4 6: Transcatheter Valve Implantation Easier Patient Recovery Responses by Region, Global, 2013
Figure 4 7: Transcatheter Valve Implantation Other Responses by Region, Global, 2013
Figure 4 8: Transcatheter Aortic Valve Implantation SAPIEN Preference by Region, Global, 2013
Figure 4 9: Transcatheter Aortic Valve Implantation CoreValve Preference by Region, Global, 2013
Figure 4 10: Clinical Outcome Responses by Region, Most Important Transcatheter Heart Implantation Device Features, Global, 2013
Figure 4 11: Lower Price Responses by Region, Most Important Transcatheter Heart Implantation Device Features, Global, 2013
Figure 4 12: Manufacturer/Distributor Relationships Responses by Region, Most Important Transcatheter Heart Implantation Device Features, Global, 2013
Figure 4 13: Ease-of-Use Reponses by Region, Most Important Transcatheter Heart Implantation Device Features, Global, 2013
Figure 4 14: Other Responses by Region, Most Important Transcatheter Heart Implantation Device Features, Global, 2013
Figure 4 15: Transcatheter Valve Implantation and Pacemaker Responses by Region, Global, 2013
Figure 4 16: Transcatheter Valve Implantation Complications Responses by Region, Global, 2013
Figure 4 17: Future Transcatheter Heart Valve Tricuspid Responses by Region, Global, 2013
Figure 4 18: Future Transcatheter Heart Valve Mitral Responses by Region, Global, 2013
Figure 4 19: Future Transcatheter Heart Valve Pulmonary Responses by Region, Global, 2013
Figure 4 20: Future Transcatheter Tricuspid Valve Procedure Responses by Region, Global, 2013
Figure 4 21: Future Transcatheter Mitral Valve Procedure Responses by Region, Global, 2013
Figure 4 22: Future Transcatheter Pulmonary Valve Procedure Responses by Region, Global, 2013
Figure 5 1: Fractional Flow Reserve Guidewire Market, U.S., 2013 – 2016
Figure 5 2: Fractional Flow Reserve Guide Market, U.S., 2013 – 2016
Figure 5 3: Average Angiography Procedures per Month by Region, Global, 2013
Figure 5 4: Percentage of Angiographies That Use FFR Guidewires by Region, Global, 2013
Figure 5 5: Percentage of Fewer Stents Used per Procedure by Region, Global, 2013
Figure 5 6: Average Fewer Stents Used per Procedure by Region, Global, 2013
Figure 5 7: PressureWire Certus Device Preference by Region, Global, 2013
Figure 5 8: FloWire Doppler Device Preference by Region, Global, 2013
Figure 5 9: PressureWire Aeris Device Preference by Region, Global, 2013
Figure 5 10: Primewire Prestige Device Preference by Region, Global, 2013
Figure 5 11: Primewire Prestige PLUS Device Preference by Region, Global, 2013
Figure 5 12: ComboWire XT Device Preference by Region, Global, 2013
Figure 5 13: Other Device Preference by Region, Global, 2013
Figure 5 14: Availability of Devices Responses by Region, Most Important FFR Device Features, Global, 2013
Figure 5 15: Price Responses by Region, Most Important FFR Device Features, Global, 2013
Figure 5 16: Clinical Outcomes Responses by Region, Most Important FFR Device Features, Global, 2013
Figure 5 17: Existing Business Relationships Responses by Region, Most Important FFR Device Features, Global, 2013
Figure 5 18: Unknown Responses by Region, Most Important FFR Device Features, Global, 2013
Figure 5 19: Price Responses by Region, Reasons for Not Using FFR Guidewires, Global, 2013
Figure 5 20: Availability of Devices Responses by Region, Reasons for Not Using FFR Guidewires, Global, 2013
Figure 5 21: Use of OCT/CT/MRI Devices Responses by Region, Reasons for Not Using FFR Guidewires, Global, 2013
Figure 5 22: Data Not Convincing Responses by Region, Reasons for Not Using FFR Guidewires, Global, 2013
Figure 5 23: Existing Business Relationships Responses by Region, Reasons for Not Using FFR Guidewires, Global, 2013
Figure 5 24: Other Responses by Region, Reasons for Not Using FFR Guidewires, Global, 2013
